{"Exaggerate": "The claim exaggerates the decrease in drug prices by stating that it is the first time in 53 years, while the expert's verdict clarifies that the measurement being referred to has not been declining for that long.", "Lack enough support": "The expert's verdict mentions that there is no good measure of drug pricing trends, indicating a lack of sufficient evidence to support the claim.", "Falters at times": "The claim falters by not accurately representing the measurement being referred to and the timeline of the decrease in drug prices, as explained by the expert's verdict.", "Problematic assumption": "The claim assumes that drug prices have gone down without considering the complexities and variations in different drugs and points in the supply chain, which the expert's verdict points out.", "Exist alternative explanation": "The expert's verdict highlights that the decrease in drug prices depends on which drugs and at which point in the supply chain, indicating alternative explanations for the claim."}